Company Snapshot

Investment Thesis

Hologic develops diagnostic, imaging, and surgical products focused on women's health, including mammography, molecular HPV/STD testing, and gynecologic surgery devices. Installed base, recurring consumables, and R&D pipeline sustain growth.

  • Mammography Leadership: 3D Genius tomosynthesis systems dominate U.S. market.
  • Molecular Diagnostics: Panther platforms, Aptima assays deliver recurring consumables.
  • GYN Surgical: NovaSure and MyoSure advance minimally invasive procedures.

Strategic Mix

Diagnostics Molecular diagnostics and cytology
Breast & Skeletal Health Imaging systems and service
GYN Surgical Devices and disposables
International Growing OUS adoption

Mix mirrors Hologic's diagnostics, breast health, and surgical business reporting.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Menu Expansion

New STI, respiratory, and oncology assays extend Panther utilization.

International Growth

Cancer screening programs spur global imaging adoption.

Capital Deployment

Buybacks and tuck-in M&A complement organic growth.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...